Comparing Blincyto vs Dasatinib
| Blincyto Remove Blincyto from your drug comparison | Dasatinib Remove Dasatinib from your drug comparison |
|---|
| Blincyto blinatumomab Remove Blincyto from your drug comparison | Dasatinib Remove Dasatinib from your drug comparison | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Acute Lymphoblastic Leukemia. Blincyto may also be used for purposes not listed in this medication guide. |
Prescribed for Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Leukemia. dasatinib may also be used for purposes not listed in this medication guide. |
||||||||
|
Prescription only |
Prescription only |
||||||||
Ratings & Reviews |
|||||||||
Drug Class |
|||||||||
Side Effects |
|||||||||
|
Common side effects include: encephalopathy, seizure disorder, febrile neutropenia, opportunistic infection, balance impairment, confusion, cytokine release syndrome, disorientation, headache, impaired consciousness, tremor, fever, hypotension, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, nausea, neutropenia, speech disturbance, and bacteremia. See the full Blincyto side effects document. |
Commonly reported side effects include: pericardial effusion, pleural effusion, pulmonary edema, dyspnea, fluid retention, and gastrointestinal hemorrhage. See the full dasatinib side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||
View all Blincyto prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Generic Availability |
|||||||||
|
No |
No |
||||||||
Dosage Form(s) Available |
|||||||||
|
N/A | ||||||||
Brand Names |
|||||||||
|
N/A |
Sprycel | ||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||
|
2.11 hours |
5 hours |
||||||||
CSA Schedule**View glossary of terms. |
|||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
|||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||
FDA Alerts |
|||||||||
|
N/A |
|||||||||
Drug Interactions |
|||||||||
|
A total of 178 drugs are known to interact with Blincyto:
|
A total of 684 drugs are known to interact with dasatinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions |
|||||||||
First Approval Date |
|||||||||
|
December 03, 2014 |
June 28, 2006 |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||
|
N/A |
N/A |
||||||||
More Information |
|||||||||
Consumer Resources |
|||||||||
Professional Resources |
|||||||||
Related Treatment Guide |
|||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.